Comparative Evaluation of Antimicrobial Efficacy of Platelet-rich Plasma, Platelet-rich Fibrin, and Injectable Platelet-rich Fibrin on the Standard Strains of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans

Prabhdeep Kour, Pushpa S Pudakalkatti, Ancia M Vas, Swetalin Das, Sreeshma Padmanabhan, Prabhdeep Kour, Pushpa S Pudakalkatti, Ancia M Vas, Swetalin Das, Sreeshma Padmanabhan

Abstract

Context: Platelet concentrates are commonly used to promote periodontal soft- and hard-tissue regeneration. Recently, their antimicrobial efficacy is also explored. Various platelet concentrates have evolved which differ in the centrifugation protocols. Porphyromonas gingivalis (Pg) and Aggregatibacter actinomycetemcomitans (Aa) have been found to have an important role in periodontal pathology.

Aims: In this study, PRP, PRF, and I-PRF are compared for their antibacterial effect against Pg and Aa.

Materials and methods: Blood samples were obtained from ten systemically and periodontally healthy individuals. Platelet concentrates were prepared using standardized centrifugation protocol. Antimicrobial activity was examined on standard strains of Pg and Aa using well diffusion method.

Statistical analysis used: Means for the width of zones of inhibition were calculated along with standard deviations, and the comparison was made using Wilcoxon signed-rank test.

Results: In case of Pg, I-PRF had the widest zone of inhibition which was significantly wider as compared to PRF. Furthermore, PRP had significantly wider zone of inhibition against PRF. In case of Aa, PRP had wider zone of inhibition which was significantly wider as compared to that of PRF and I-PRF.

Conclusions: All the three platelet concentrates PRP, PRF, and I-PRF have antibacterial activity, but PRP and I-PRF are more active as compared to PRF. I-PRF being autologous and easy to prepare can be a very useful adjunct to the surgical therapy in bringing down the bacterial count helping in wound healing and regeneration.

Keywords: Antibacterial activity; injectable platelet-rich fibrin; platelet-rich fibrin; platelet-rich plasma.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Prepared injectable platelet-rich fibrin (a), platelet-rich fibrin (b), and platelet-rich plasma (c)
Figure 2
Figure 2
Samples added to the wells prepared in agar plates inoculated with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans
Figure 3
Figure 3
(a) Zones of inhibition observed around platelet-rich plasma and injectable platelet-rich fibrin but not so distinct around platelet-rich fibrin. (Porphyromonas gingivalis) (b) Zones of inhibition observed around platelet-rich plasma and injectable platelet-rich fibrin but not so distinct around platelet-rich fibrin (Aggregatibacter actinomycetemcomitans)

References

    1. Carranza FA, Newman MG, Takei HH, Klokkevold PR. Carranza's Clinical Periodontology. 10th Edition. Saunders Co., Lindo: 2006.
    1. Torrungruang K, Jitpakdeebordin S, Charatkulangkun O, Gleebbua Y. Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Treponema denticola/Prevotella intermedia co-infection are associated with severe periodontitis in a Thai population. PLoS One. 2015;10:e0136646.
    1. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:e37–44.
    1. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate? Part III: Leucocyte activation: A new feature for platelet concentrates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:e51–5.
    1. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, et al. Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol. 2007;78:661–9.
    1. Del Fabbro M, Ceresoli V, Lolato A, Taschieri S. Effect of platelet concentrate on quality of life after periradicular surgery: A randomized clinical study. J Endod. 2012;38:733–9.
    1. Bertrand-Duchesne MP, Grenier D, Gagnon G. Epidermal growth factor released from platelet-rich plasma promotes endothelial cell proliferation in vitro. J Periodontal Res. 2010;45:87–93.
    1. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638–46.
    1. Anitua E, Troya M, Orive G. Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-β1-induced myodifferentiation. J Periodontol. 2012;83:1028–37.
    1. Anitua E, Tejero R, Zalduendo MM, Orive G. Plasma rich in growth factors promotes bone tissue regeneration by stimulating proliferation, migration, and autocrine secretion in primary human osteoblasts. J Periodontol. 2013;84:1180–90.
    1. Anitua E, Troya M, Orive G. An autologous platelet-rich plasma stimulates periodontal ligament regeneration. J Periodontol. 2013;84:1556–66.
    1. Choukroun J, Adda F, Schoeffer C, Vervelle A. PRF: An opportunity in perio-implantology. Implantodontie. 2000;42:55–62.
    1. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:e56–60.
    1. Dohan Ehrenfest DM, Diss A, Odin G, Doglioli P, Hippolyte MP, Charrier JB, et al. In vitro effects of choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:341–52.
    1. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in choukroun's platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors. 2009;27:63–9.
    1. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91:4–15.
    1. Choukroun J. Advanced PRF & I-PRF: Platelet concentrates or blood concentrates? J Periodontal Med Clin Pract. 2014;1:3.
    1. Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, et al. Injectable platelet rich fibrin (i-PRF): Opportunities in regenerative dentistry? Clin Oral Investig. 2017;21:2619–27.
    1. Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008;26:404–10.
    1. Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T, et al. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br. 2007;89:417–20.
    1. Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G, et al. Antibacterial effect of plasma rich in growth factors (PRGF®-endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol. 2012;37:652–7.
    1. Drago L, Bortolin M, Vassena C, Taschieri S, Del Fabbro M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol. 2013;13:47.
    1. Yang LC, Hu SW, Yan M, Yang JJ, Tsou SH, Lin YY, et al. Antimicrobial activity of platelet-rich plasma and other plasma preparations against periodontal pathogens. J Periodontol. 2015;86:310–8.
    1. Badade PS, Mahale SA, Panjwani AA, Vaidya PD, Warang AD. Antimicrobial effect of platelet-rich plasma and platelet-rich fibrin. Indian J Dent Res. 2016;27:300–4.
    1. Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol. 1967;38:Suppl: 610–6.
    1. Preeja C, Arun S. Platelet-rich fibrin: Its role in periodontal regeneration. Saudi J Dent Res. 2014;5:117–22.
    1. Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, et al. Advanced platelet-rich fibrin: A new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014;40:679–89.
    1. Joshi CP, Patil AG, Karde PA, Khedkar SU, Mahale SA, Dani NH, et al. Autologous platelet rich fibrin as a potential antiperiopathogenic agent: An in-vitro study. Int J Periodontol Implantol. 2016;1:50–4.
    1. Karde PA, Sethi KS, Mahale SA, Khedkar SU, Patil AG, Joshi CP, et al. Comparative evaluation of platelet count and antimicrobial efficacy of injectable platelet-rich fibrin with other platelet concentrates: An in vitro study. J Indian Soc Periodontol. 2017;21:97–101.
    1. Nagaoka S, Murata S, Kimura K, Mori T, Hojo K. Antimicrobial activity of sodium citrate against Streptococcus pneumoniae and several oral bacteria. Lett Appl Microbiol. 2010;51:546–51.
    1. Saini R, Saini S, Sharma S. Therapeutics of stem cells in periodontal regeneration. J Nat Sci Biol Med. 2011;2:38–42.
    1. Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis. 1997;25:951–68.
    1. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002;70:6524–33.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する